Filter
1803
Filtered Results: 1803
Text search:
pharmaceutical
needs
Featured
Recommendations
163
New Publications
506
Language
Document type
No document type
969
Studies & Reports
327
Guidelines
258
Manuals
89
Strategic & Response Plan
86
Fact sheets
23
Training Material
22
Situation Updates
14
Resource Platforms
5
Infographics
5
Brochures
3
Online Courses
2
Countries / Regions
India
79
Kenya
71
Ethiopia
69
Global
68
South Africa
50
Western and Central Europe
44
Nigeria
42
Uganda
40
Liberia
36
Sierra Leone
34
Namibia
25
Nepal
24
Zambia
24
Tanzania
24
Rwanda
24
Bangladesh
23
Malawi
23
Ukraine
23
Ghana
22
Africa
22
Syria
19
Eastern Europe
19
Zimbabwe
17
Philippines
17
Cambodia
16
Lesotho
15
South–East Asia Region
14
Latin America and the Carribbean
14
Indonesia
12
Myanmar / Burma
11
Eswatini/ Swaziland
10
West and Central Africa
9
South Sudan
8
Botswana
8
East and Southern Africa
8
Eastern Europe and Central Asia
8
Congo, Democratic Republic of
7
Cameroon
7
Germany
7
Asia
7
Venezuela
7
Senegal
6
Haiti
6
Guinea
5
Burkina Faso
5
Pakistan
5
Middle East and North Africa
5
Western Pacific Region
5
Papua New Guinea
4
Vietnam
4
Mali
3
USA
3
Jordan
3
Afghanistan
3
Lebanon
3
Egypt
3
Thailand
3
Mozambique
3
Brazil
3
North Macedonia
3
Albania
3
Laos
3
Russia
3
North America
3
United Kingdom
3
Iraq
2
China
2
Sudan
2
Benin
2
Central African Republic
2
Peru
2
Serbia
2
Yemen
2
Fiji
2
Southern Africa
2
Lithuania
2
Moldova
2
Kyrgyzstan
2
Georgia
2
Jamaica
2
Saudi Arabia
1
Niger
1
Somalia
1
Chad
1
Malaysia
1
Ireland
1
El Salvador
1
Libya
1
Sri Lanka
1
Bhutan
1
Palestine
1
Armenia
1
Canada
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Romania
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Japan
1
Belgium
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
749
Clinical Guidelines
117
Public Health
100
Key Resources
70
Women & Child Health
46
Pharmacy & Technologies
25
Capacity Building
13
Annual Report MEDBOX
2
Toolboxes
AMR
158
Pharmacy
154
COVID-19
136
Mental Health
107
HIV
100
TB
85
Rapid Response
56
NCDs
42
Planetary Health
40
Caregiver
39
NTDs
38
Global Health Education
35
Conflict
34
Ebola
30
Health Financing Toolbox
26
Disability
15
Refugee
14
Specific Hazards
12
Polio
11
Natural Hazards
9
Cholera
4
Zika
3
Social Ethics
3
Health Financing
2
South Sudan
1
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of ... products; storage of pharmaceutical products; and distribution of pharmaceutical products.
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically ...
World Journal of Pharmaceutical and Medical Research vol. 5 (2019) 3, 129-132
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out h...
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivud...
Infection Control Assessment Tool
recommended
Strengthening Parmaceutical Systems. 2nd edition
Guidelines for Handling Temperature Sensitive Vaccines and Pharmaceuticals
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), ... may constitute as much as 40% of the national health budget in developing countries, yet portions of the population may lack access to the most essential medicines; while the limited funds available for health are spent on unnecessary, ineffective and even dangerous medications.
WHO Annual Meeting with Pharmaceutical Companies and Stakeholders
08 March 2016, Geneva
2015-06-03 - Board presentation - v32.pptx
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
Essential Medicines are those that satisfy the priority health care needs of the population. They are selected with due regard to public health relevance, evidence on efficacy, safety and comparative cost-effectiveness. This edition of the Essential...
It is impossible to address the many complex needs of respiratory virus surveillance with a single surveillance system. Multiple systems, investigations and studies must each be fit-for-purpose to specific priority surveillance objectives, and only ...
The essential medicines are those that meet the priority needs of the healthcare of the population. While reviewing the 5th edition of the essential Medicines, special attention focused on the health sector policy. Indeed, medicines play an importa...
Namibia guideline for submission of applications for registration of pharmaceuticals for human use in common technical document format.
The figures and findings reflected in the 2020 PMR represent the independent analysis of the United Nations (UN) and its humanitarian partners based on information available to them. Many of the figures provided throughout the document are estimates based on sometimes incomplete and partial data set...
This ten year global plan for measles and rubella outlines the strategy that needs to be fully implemented to achieve the measles and rubella goals endorsed by the World Health Assembly. The plan sets out the: vision, goals and targets for the 2011-...
The objectives of NAP are aligned with the global action plan based on national needs and priorities. The emphasis is on One Health approach with all sectors especially human health, animal health and environment contributing towards minimizing the ...
A WHO-UNICEF joint statement encouraging greater health commodity supply chain integration for temperature-sensitive pharmaceuticals where appropriate, 19 November 2020
The Kenyan Health Sector has been playing a critical role in
providing health care services in response to the population
needs in line with the Kenya Health Policy, 2014-2030’s goal
of attaining the highest possible health standards in a manne...
The Adult Standard Treatment Guidelines and Essential Medicines List for Hospital Level provide a platform for transparency to enable equitable access to safe, effective, and affordable treatment options at hospital level taking into consideration the changing clinical ... of our population and the pragmatic implications of the introducing a new health technology.
